A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...
Last week, researchers dropped a bombshell report on DFNZ, a developing new medicine derived from a class of drugs once ...
The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.
Please provide your email address to receive an email when new articles are posted on . Sensitivities to acetaminophen and NSAIDs are common but vary. Topical pain relief solutions may provide fewer ...
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill received ...
This article examines emerging non-opioid strategies for chronic pain, from targeted ion-channel drugs and anti-inflammatory ...
Add Yahoo as a preferred source to see more of our stories on Google. Suzetrigine is a prescription pill taken every 12 hours after a larger starter dose. (Vertex Pharmaceuticals) The US Food and Drug ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. On Thursday, the Food and Drug Administration (FDA) granted approval to Vertex Pharmaceuticals' non-opioid painkiller ...
Please provide your email address to receive an email when new articles are posted on . Chronic low back pain is one of the most frequent and challenging conditions encountered in primary care.
Lung cancer causes abnormal cells to grow in your lungs. You are at higher risk for lung cancer if you are a current smoker or have smoked regularly in the past. But anyone can get lung cancer. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results